Drug Discovery World Podcast: The unmet critical need for concussion drug therapies
The CEO of Oxeia, Dr. Michael Wyand, talks with Drug Discovery World’s multimedia editor, Megan Thomas, about the unmet critical need for effective concussion therapies, Oxeia’s Phase 2a clinical trials, the challenges facing Oxeia as the company gears up for full-scale Phase 2 trials and the potential market for concussion drugs